Drug Type Bispecific antibody |
Synonyms anti-TfR scFv + anti-CD49d scFv |
Target |
Action- |
Mechanism CD49d antagonists(Integrin alpha-4 antagonists), TfR1 antagonists(Transferrin receptor protein 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Sclerosis | Discovery | Taiwan Province | - |





